HS-235

N/A

Report date: 2024/12/13 10:48:19

Base Information

Drug NameHS-235
Drug Alias NameHS235HS-235
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionActivin inhibitors
TargetsActivins
Therapy Area/IndicationsOverweightObesityHeart Failure, Diastolic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator Companies35Pharma Inc
China Registration ClassN/A

Develop Information

Active Companies35Pharma Inc
Inactive CompaniesN/A
Active IndicationsOverweightObesityHeart Failure, Diastolic +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A